Skip to content

Clinical trials

Phase 2 Lung Neoplasms trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Phase 2 Country / region: Belgium Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20041
20051
20063
20071
20101
20111
20122
20131
20152
20161
20191
20223
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting3
Terminated3
Active, not recruiting2
Unknown status2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company4
European Organisation for Research and Treatment of Cancer - EORTC4
Novartis Pharmaceuticals4
Universitair Ziekenhuis Brussel2
University Hospital, Antwerp2
Actuate Therapeutics Inc.1
AstraZeneca1
Boehringer Ingelheim1
Daiichi Sankyo1
OncoMed Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms24
Carcinoma, Non-Small-Cell Lung16
Adenocarcinoma of Lung4
Neoplasm Metastasis3
Pancreatic Neoplasms3
Breast Neoplasms2
Lung Diseases2
Melanoma2
Neoplasms2
Urinary Bladder Neoplasms2

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.